Transcript Slide 1

Communication is the Key
Pharmacy Purchasing Pearls
Marvin Finnefrock, PharmD
Steven L. Gratch, Pharm. B.Sc., R.Ph.
Diane Daskey
Joanie MacIntosh, CPhT
Learning Objectives
(for Technicians & Pharmacists)

At the end of this activity, the participant will be
able to:




Describe the role of the pharmacy buyer in preparing for P&T meetings.
Outline the communication relationships between manufacturer,
wholesaler, GPO, pharmacy buyer, pharmacy staff, clinical pharmacists,
and pharmacy director.
Differentiate circumstances and situations that may be managed by the
pharmacy buyer versus clinical pharmacists versus pharmacy
management.
Describe the “glue” required for effective communication within and
outside of the pharmacy department.
Presentation Overview
Buyer and
pharmacy
team
Vendors and
GPO
Patient
Administration
Medical and
Nursing Staff
Buyer Support for the Clinical Pharmacist

The clinical specialist should work very closely
with the Pharmacy buyer/purchasing agent

Tell them what they do not know

Think outside the package

Know the formulary and empower yourself
The Connection Between Pharma,
Wholesaler, GPO & Pharmacy Buyer
GPO
Manufacturer
Pharmacy
Buyer
Pharmacy
Operations
Wholesaler
Group Purchasing Organization
Contract Compliance
 Business Class



DEA Status
“Not for” or “For” profit status
Group Purchasing Organization

Robinson Patman Act

Sets rules for discount pricings




Litmus test = “Own Use”



Business Class (DEA license status)
Volume Discounts
Formulary restrictions
Patients register to the facility
Employees
Profit Status – exemptions for “Not for Profit”

Limited dispensing – inpatient ED and hospital outpatients
Wholesale Distributors

Prescription Drug Marketing Act of 1987




Amended in 1992 and 2006
Regulates resale of drugs by hospitals
States must license Wholesalers
FDA 5% rules annual sales to other pharmacies
without Wholesale License


States may have a more stringent regulations
Drug Pedigree
Resale to hospital own outpatient pharmacy
 Resale to clinics and physician offices

Pharmaceutical Sales Representatives
An important role in providing medication
information they are guest of the hospital and
expected to follow hospital policies
 HIPPA, PHRMA Accepted Rules of Conduct and
Security
 Verify contact information including
representative’s district/regional manager
 Sign Acknowledgement of understanding
hospital rules

Pharmaceutical Sales Representatives

Set the expectations for service:



Contact with Physician and Staff



Educational programs
Information displays
Location restrictions
Discussion of P&T activities
Penalties for inappropriate activities
Pathway to P&T
Preparation
Tools
Pharmacy
Buyer
Drug
Shortages
Analysis
Preparation to bring a new drug onto
formulary

Manufacturer






Contracts/LOP’s/LOC’s
Reimbursement/HCPCS
codes
Storage and Handling
Shelf life
Patient Assistant Programs
Educational plan for
Medical and Pharmacy
staff

DOP or Clinical RPH




Therapeutic Indication
Where will item be stocked
Suspected Usage
Start up Min/Max levels
Cost Analysis
Cost Comparison to similar medications
currently on formulary
 Correct Contract tiers based on market share.
 340 pricing if eligible.

Shortage Report
New Shortages
 Ongoing Shortages
 Permanent Outages
 Resolved Shortages





Reason for Shortage
Expected Release Date
Product Management
Supply information
Shortage Report - Sample
Pharmacy Bulletin June 2011
National Backorders - Drug Shortages
Medication
Reason for Shortage
Expected Release Date
none given
TBD
Product Management
Supply Information
bisacodyl suppositories
#6 in the pharmacy and #4 in
pyxis
New Shortages
Bisacodyl Enema 10mg/30ml
Ongoing Shortages
Acetylcysteine 10% and 20% American Regent supply
vials
issues
Late May for 10ml and larger ordered in 10ml and 30ml
sizes; 4ml TBD
vials to compound 4ml
inhalation as needed
10% - #30 4ml vials; 9 10ml
vials; 20 30ml vials; 20% - #12
4ml vials; #0 30ml vials
Permanent Outages
Baygam
Discontinued
Acyclovir Sodium Injection
Intermittent shortages due to
increased demand and mfr
delays
Gamastan
0
Resolved Shortages
APP has product available for 10ml -30 vials on hand ;20ml direct ship
30 vials on hand
The Buyer is the “Glue”
Pharmacy
Staff
Medical
Staff
Pharmacy
Management
Team
Patient
Pharmacy Staff

Ordering



Shortages




Two way Communication
Shortages and Recalls
Anticipated length
Allocation
Alternative item
Recalls

Anticipated length
Pharmacy Staff

Formulary Management



Additions/Deletions
New CDM’s
Location of Product

Location, Location, Location!
Medical Staff

Drug Shortages



Recalls




Anticipated Length
Alternative Item
Ancillary Departments
Clinics
Physician Offices
Newsletters


ISMP
Pharmacy Newsletter

Formulary Updates
Pharmacy Management Team
Pharmacy Buyer
 Drug Shortages
 Recalls
 Contract Updates
 Vendor Representative
Update

New products



Pricing
Availability
Reports

Budget
Pharmacy Management
Team
 DOP



Clinical


Budget
New Services
New Initiatives
Technician Supervisor


Automation
Scheduling
Patient
Drug Shortages
 Recalls
 Non-Formulary Items

Communication is the Key
Pharmacy Purchasing Pearls